StonvexLoading…
StonvexStonvexStonvexCore line items from KEEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $36.99M | $229.28M | $47.65M | $133.27M |
Operating Income | $-98.39M | $-149.60M | $-34.84M | $-28.01M |
Net Income | $-145.35M | $-284.54M | $-55.55M | $-28.36M |
EPS (Diluted) | $-0.24 | $-0.52 | $-0.11 | $-0.07 |
Total Assets | $1.07B | $1.30B | Not available | $663.13M |
Total Liabilities | $647.58M | $735.97M | Not available | $51.99M |
Cash & Equivalents | $398.35M | $630.96M | $38.55M | $59.54M |
Free Cash Flow OCF − CapEx | $-75.01M | $-326.89M | $-62.18M | $-428.63M |
Shares Outstanding | 602.85M | 601.58M | 553.64M | 479.33M |